These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1640806)

  • 41. Behavior and drug measurements in Long-Evans and Sprague-Dawley rats after ethanol-cocaine exposure.
    Horowitz JM; Bhatti E; Devi BG; Torres G
    Pharmacol Biochem Behav; 1999 Feb; 62(2):329-37. PubMed ID: 9972701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects.
    Foltin RW; Haney M
    Pharmacol Biochem Behav; 2004 May; 78(1):93-101. PubMed ID: 15159138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrimination of cocaethylene in rats trained to discriminate between its components.
    Schechter MD
    Eur J Pharmacol; 1997 Feb; 320(1):1-7. PubMed ID: 9049595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat hepatocytes.
    Boelsterli UA; Wolf A; Göldlin C
    Hepatology; 1993 Nov; 18(5):1154-61. PubMed ID: 8225222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between marihuana and ethanol: effects on psychomotor performance.
    Perez-Reyes M; Hicks RE; Bumberry J; Jeffcoat AR; Cook CE
    Alcohol Clin Exp Res; 1988 Apr; 12(2):268-76. PubMed ID: 2837105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.
    Foltin RW; Ward AS; Collins ED; Haney M; Hart CL; Fischman MW
    Exp Clin Psychopharmacol; 2003 May; 11(2):123-30. PubMed ID: 12755456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of HERG potassium channels by cocaethylene: a metabolite of cocaine and ethanol.
    O'Leary ME
    Cardiovasc Res; 2002 Jan; 53(1):59-67. PubMed ID: 11744013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of cocaethylene in toxic symptoms due to repeated subcutaneous cocaine administration modified by oral doses of ethanol.
    Hayase T; Yamamoto Y; Yamamoto K
    J Toxicol Sci; 1999 Aug; 24(3):227-35. PubMed ID: 10478337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alcohol-induced inhibition of cocaine metabolism and the formation of cocaethylene in neonatal rats.
    Chen WJ; West JR
    Neurotoxicol Teratol; 1998; 20(5):565-70. PubMed ID: 9761596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studies.
    Nobiletti JB; Jatlow PI; Bradberry CW
    Psychopharmacology (Berl); 1994 Nov; 116(3):273-8. PubMed ID: 7892416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cocaine pharmacokinetics in ethanol-pretreated rats.
    Levine BS; Tebbett IR
    Drug Metab Dispos; 1994; 22(3):498-500. PubMed ID: 8070329
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects.
    Lukas SE; Kouri EM; Rhee C; Madrid A; Renshaw PF
    Psychopharmacology (Berl); 2001 Sep; 157(2):163-7. PubMed ID: 11594440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter.
    Hearn WL; Flynn DD; Hime GW; Rose S; Cofino JC; Mantero-Atienza E; Wetli CV; Mash DC
    J Neurochem; 1991 Feb; 56(2):698-701. PubMed ID: 1988563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of cocaine and cocaethylene in blood and tissues by GC-NPD and GC-ion trap mass spectrometry.
    Hime GW; Hearn WL; Rose S; Cofino J
    J Anal Toxicol; 1991; 15(5):241-5. PubMed ID: 1960973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion.
    Jatlow P; Elsworth JD; Bradberry CW; Winger G; Taylor JR; Russell R; Roth RH
    Life Sci; 1991; 48(18):1787-94. PubMed ID: 2020260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between cocaine and cocaethylene blood concentration with the severity of clinical manifestations.
    Zucoloto AD; Eller S; de Oliveira TF; Wagner GA; Fruchtengarten LVG; de Oliveira CDR; Yonamine M
    Am J Emerg Med; 2021 Dec; 50():404-408. PubMed ID: 34481259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of chronic naltrexone treatment in rats on place preference and locomotor activation after acute administration of cocaethylene or ethanol plus cocaine.
    Sable HJ; White SL; Steinpreis RE
    Alcohol; 2004 May; 33(1):51-61. PubMed ID: 15353173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cocaine metabolism in humans after use of alcohol. Clinical and research implications.
    Cami J; Farré M; González ML; Segura J; de la Torre R
    Recent Dev Alcohol; 1998; 14():437-55. PubMed ID: 9751958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitization to the locomotor activating effects of cocaine following cocaethylene-preexposure.
    Horger BA; Taylor JR; Elsworth JD; Jatlow PI; Roth RH
    Brain Res; 1996 Sep; 733(1):133-7. PubMed ID: 8891259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of cocaine and cocaine metabolites on cardiovascular function in squirrel monkeys.
    Schindler CW; Zheng JW; Goldberg SR
    Eur J Pharmacol; 2001 Nov; 431(1):53-9. PubMed ID: 11716843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.